» Articles » PMID: 34136819

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients

Abstract

Design: Retrospective analysis of prospectively collected observational data.

Setting: University-affiliated adult ICU.

Patients: Ninety-two coronavirus disease 2019 patients admitted to the ICU from February 21, 2020, to May 6, 2020.

Interventions: None.

Measurements And Main Results: The prevalence of superinfection at ICU admission was 21.7%, and 53 patients (57.6%) had at least one superinfection during ICU stay, with a total of 75 (82%) ventilator-associated pneumonia and 57 (62%) systemic infections. The most common pathogens responsible for ventilator-associated pneumonia were ( = 26, 34.7%) and ( = 14, 18.7%). Bloodstream infection occurred in 16 cases, including methicillin-resistant ( = 8, 14.0%), species ( = 6, 10.5%), and species ( = 2, 3.5%). Fungal infections occurred in 41 cases, including 36 probable (30 by , six by ) and five proven invasive candidiasis (three , two ). Presence of bacterial infections (odds ratio, 10.53; 95% CI, 2.31-63.42; = 0.005), age (odds ratio, 1.17; 95% CI, 1.07-1.31; = 0.001), and the highest Sequential Organ Failure Assessment score (odds ratio, 1.27; 95% CI, 1.06-1.63; = 0.032) were independently associated with ICU or 28-day mortality.

Conclusions: Prevalence of superinfections in coronavirus disease 2019 patients requiring mechanical ventilation was high in this series, and bacterial superinfections were independently associated with ICU or 28-day mortality (whichever comes first).

Citing Articles

Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis.

Zuniga-Moya J, Papadopoulos B, Mansoor A, Mazi P, Rauseo A, Spec A Open Forum Infect Dis. 2024; 11(4):ofae108.

PMID: 38567199 PMC: 10986750. DOI: 10.1093/ofid/ofae108.


Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.

Langford B, So M, Simeonova M, Leung V, Lo J, Kan T Lancet Microbe. 2023; 4(3):e179-e191.

PMID: 36736332 PMC: 9889096. DOI: 10.1016/S2666-5247(22)00355-X.


Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report.

Kovacevic P, Topolovac S, Dragic S, Jandric M, Momcicevic D, Zlojutro B Medicina (Kaunas). 2022; 58(12).

PMID: 36556932 PMC: 9781202. DOI: 10.3390/medicina58121730.


Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania.

Novacescu A, Buzzi B, Bedreag O, Papurica M, Rogobete A, Sandesc D Infect Drug Resist. 2022; 15:7001-7014.

PMID: 36478964 PMC: 9721122. DOI: 10.2147/IDR.S390681.


COVID-19 Secondary Infections in ICU Patients and Prevention Control Measures: A Preliminary Prospective Multicenter Study.

Ruiz-Santana S, Mora-Quintero M, Saavedra P, Montiel-Gonzalez R, Sanchez-Ramirez C, Perez-Acosta G Antibiotics (Basel). 2022; 11(8).

PMID: 36009884 PMC: 9405068. DOI: 10.3390/antibiotics11081016.


References
1.
Lombardy Section Italian Society Infectious And Tropical Diseases - . Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020. Infez Med. 2020; 28(2):143-152. View

2.
Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F . Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020; 19(7):102568. PMC: 7252115. DOI: 10.1016/j.autrev.2020.102568. View

3.
Contou D, Claudinon A, Pajot O, Micaelo M, Longuet Flandre P, Dubert M . Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020; 10(1):119. PMC: 7475952. DOI: 10.1186/s13613-020-00736-x. View

4.
Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L . Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis. 2020; 73(11):e3606-e3614. PMC: 7454393. DOI: 10.1093/cid/ciaa1065. View

5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View